These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Orally disintegrating olanzapine and potential differences in treatment-emergent weight gain.
    Author: Karagianis J, Hoffmann VP, Arranz B, Treuer T, Maguire GA, de Haan L, Chawla B.
    Journal: Hum Psychopharmacol; 2008 Jun; 23(4):275-81. PubMed ID: 18338426.
    Abstract:
    Several papers and communications have reported possible weight reduction or less weight gain when patients start or switch to orally disintegrating olanzapine, as contrasted with standard oral olanzapine tablets. In this paper, the current literature is reviewed and hypothesized mechanisms of action are discussed. The data are still preliminary and mechanisms of action are not well understood. Randomized controlled trials are needed to further evaluate change in weight during treatment with orally disintegrating olanzapine.
    [Abstract] [Full Text] [Related] [New Search]